FDA Inspection
Labcorp Early Development Laboratories, Inc.Labcorp Early Development Laboratories, Inc. – FDA Inspection, May 7, 2025
Record Details
This FDA Inspection record concerns Labcorp Early Development Laboratories, Inc., with an inspection on May 7, 2025, issued by the Minneapolis District Office, covering biologics.
View Company Profile
ID · 03baebe6-56aa-43ed-98d2-19c66733b02b
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1269784
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
1- 21 CFR 58.33(f)Study director: transfer of data to archives
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Labcorp Early Development Laboratories, Inc.
8| Date | Classification | Office | Project area |
|---|---|---|---|
| August 30, 2023 | VAI | Minneapolis District Office | |
| February 14, 2020 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| September 5, 2019 | Not classified | Minneapolis District Office | |
| August 24, 2018 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| August 17, 2018 | VAI | Minneapolis District Office | Bioresearch Monitoring |
Other documents for Labcorp Early Development Laboratories, Inc.
- FDA Inspection 1216326 - 2023-08-30
- FDA Inspection 1121677 - 2020-02-14
- FDA Inspection 1106741 - 2019-09-05
- FDA Inspection 1065286 - 2018-08-24
- FDA Inspection 1064823 - 2018-08-17
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.